A correlation of haloperidol-induced cognitive deficit with dysfunctional dopamine receptor activity in nonhuman primate

References

• Carter C, Robertson L, Nordahl T, Chaderjian M, Kraft L, O’Shora-Celaya L. Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients. Biol Psychiatry. 1996;40(9):930–932.
   Web of Science ®Google Scholar
• Park S, Puschel J, Sauter BH, Rentsch M, Hell D. Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study. Biol Psychiatry. 1999;46(3):392–400.
   Web of Science ®Google Scholar
• Weinberger DR, Aloia MS, Goldberg TE, Berman KF. The frontal lobes and schizophrenia. J Neuropsychiatry Clin Neurosci. 1994;6(4):419–427.
   PubMed Web of Science ®Google Scholar
• Wong AH, Van Tol HH. Schizophrenia: from phenomenology to neurobiology. Neurosci Biobehav Rev. 2003;27(3):269–306.
   PubMed Web of Science ®Google Scholar
• McEvoy JP. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. J Clin Psychopharmacol. 1983;3(5):288–302.
   Web of Science ®Google Scholar
• Wadenberg ML, Kapur S, Soliman A, Jones C, Vaccarino F. Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats. Psychopharmacology (Berl). 2000;150(4):422–429.
   Web of Science ®Google Scholar
• Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209–1223.
   PubMed Web of Science ®Google Scholar
• Goldstein JM. The new generation of antipsychotic drugs: how atypical are they? Int J Neuropsychopharmacol. 2000;3(4):339–349.
   PubMed Web of Science ®Google Scholar
• Andreassen OA, Jorgensen HA. The rat model of tardive dyskinesia: relationship between vacuous chewing movements and gross motor activity during acute and long-term haloperidol treatment. Life Sci. 1995;57(24):2263–2272.
   Web of Science ®Google Scholar
• Egan MF, Hurd Y, Ferguson J, Bachus SE, Hamid EH, Hyde TM. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol. Psychopharmacology (Berl). 1996;127(4):337–345.
   Web of Science ®Google Scholar
• Trevitt JT, Lyons M, Aberman J, Carriero D, Finn M, Salamone JD. Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function. Psychopharmacology (Berl). 1997;132(1):74–81.
   Web of Science ®Google Scholar
• Saller CF, Salama AI. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo. J Pharmacol Exp Ther. 1986;236(3):714–720.
   Web of Science ®Google Scholar
• Stoof JC, Kebabian JW. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature. 1981;294(5839):366–368.
   Web of Science ®Google Scholar
• Waddington JL. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacol (Berl). 1990;101(4):431–447.
   Web of Science ®Google Scholar
• Groenewegen HJ. The basal ganglia and motor control. Neural Plast. 2003;10(1–2):107–120.
   PubMedGoogle Scholar
• Gurney K, Prescott TJ, Wickens JR, Redgrave P. Computational models of the basal ganglia: from robots to membranes. Trends Neurosci. 2004;27(8):453–459.
   PubMed Web of Science ®Google Scholar
• Weinberger DR, Berman KF, Zec RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry. 1986;43(2):114–124.
   PubMed Web of Science ®Google Scholar
• Lewis DA, Anderson SA. The functional architecture of the prefrontal cortex and schizophrenia. Psychol Med. 1995;25(5):887–894.
   Web of Science ®Google Scholar
• Manoach DS, Press DZ, Thangaraj V, et al. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry. 1999;45(9):1128–1137.
   PubMed Web of Science ®Google Scholar
• Castner SA, Williams GV, Goldman-Rakic PS. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science. 2000;287(5460):2020–2022.
   PubMed Web of Science ®Google Scholar
• Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science. 1976;192(4238):481–483.
   PubMed Web of Science ®Google Scholar
• Glovinsky D, Kirch DG, Wyatt RJ. Early antipsychotic response to resumption of neuroleptics in drug-free chronic schizophrenic patients. Biol Psychiatry. 1992;31(9):968–970.
   Web of Science ®Google Scholar
• Carr VJ. Recovery from schizophrenia: a review of patterns of psychosis. Schizophr Bull. 1983;9(1):95–121.
   Web of Science ®Google Scholar
• Keck PE Jr, Cohen BM, Baldessarini RJ, McElroy SL. Time course of antipsychotic effects of neuroleptic drugs. Am J Psychiatry. 1989;146(10):1289–1292.
   Web of Science ®Google Scholar
• Stern RG, Kahn RS, Harvey PD, Amin F, Apter SH, Hirschowitz J. Early response to haloperidol treatment in chronic schizophrenia. Schizophr Res. 1993;10(2):165–171.
   Web of Science ®Google Scholar
• Sgambato V, Pages C, Rogard M, Besson MJ, Caboche J. Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation. J Neurosci. 1998;18(21):8814–8825.
   Web of Science ®Google Scholar
• Gerfen CR, Miyachi S, Paletzki R, Brown P. D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J Neurosci. 15 2002;22(12):5042–5054.
   Web of Science ®Google Scholar
• Goldman PS, Rosvold HE, Mishkin M. Evidence for behavioral impairment following prefrontal lobectomy in the infant monkey. J Comp Physiol Psychol. 1970;70(3):454–463.
   Web of Science ®Google Scholar
• Lopez-Tellez JF, Lopez-Aranda MF, Navarro-Lobato I, et al. Prefrontal inositol triphosphate is molecular correlate of working memory in nonhuman primates. J Neurso Sci. 2010;30(8):3067–3071.
   Google Scholar
• Khan ZU, Gutierrez A, De Blas AL. Short and long form gamma 2 subunits of the GABAA/benzodiazepine receptors. J Neurochem. 1994;63(4):1466–1476.
   Web of Science ®Google Scholar
• Khan ZU, Mrzljak L, Gutierrez A, de la Calle A, Goldman-Rakic PS. Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci U S A. 1998;95(13):7731–7736.
   Web of Science ®Google Scholar
• Khan ZU, Gutierrez A. Distribution of C-terminal splice variant of G alpha i2 in rat and monkey brain. Neuroscience. 2004;127(4): 833–843.
   Web of Science ®Google Scholar
• Khan ZU, Gutierrez A, Martin R, Penafiel A, Rivera A, de la Calle A. Dopamine D5 receptors of rat and human brain. Neuroscience. 2000;100(4):689–699.
   Web of Science ®Google Scholar
• Sharma T, Mockler D. The cognitive efficacy of atypical antipsychotics in schizophrenia. J Clin Psychopharmacol. 1998;18(2 Suppl 1):12S–19S.
   PubMed Web of Science ®Google Scholar
• Fuster JM. Memory in the cortex of the primate. Biol Res. 1995;28(1):59–72.
   PubMedGoogle Scholar
• Fritts ME, Asbury ET, Horton JE, Isaac WL. Medial prefrontal lesion deficits involving or sparing the prelimbic area in the rat. Physiol Behav. 1998;64(3):373–380.
   Web of Science ®Google Scholar
• Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 1976;261(5562):717–719.
   PubMed Web of Science ®Google Scholar
• Luchins D. The dopamine hypothesis of schizophrenia. A critical analysis. Neuropsychobiol. 1975;1(6):365–378.
   Google Scholar
• Meltzer HY, Stahl SM. The dopamine hypothesis of schizophrenia: a review. Schizophr Bull. 1976;2(1):19–76.
   PubMed Web of Science ®Google Scholar
• Sayed Y, Garrison JM. The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs-a review. Psychopharmacol Bull. 1983;19(2):283–288.
   Google Scholar
• Snyder SH. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry. 1976;133(2):197–202.
   PubMed Web of Science ®Google Scholar
• van Kammen DP. The dopamine hypothesis of schizophrenia revisited. Psychoneuroendocrinol. 1979;4(1):37–46.
   Web of Science ®Google Scholar
• Burt DR, Creese I, Snyder SH. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science. 1977;196(4287):326–328.
   PubMed Web of Science ®Google Scholar
• Seeman P. Brain dopamine receptors. Pharmacol Rev. 1980;32(3): 229–313.
   Web of Science ®Google Scholar
• O’Dell SJ, La Hoste GJ, Widmark CB, Shapiro RM, Potkin SG, Marshall JF. Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse. 1990;6(2):146–153.
   Web of Science ®Google Scholar
• Jeste DV, Wyatt RJ. In search of treatment for tardive dyskinesia: review of the literature. Schizophr Bull. 1979;5(2):251–293.
   Web of Science ®Google Scholar
• Baldessarini RJ, Tarsy D. Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu Rev Neurosci. 1980;3:23–41.
   PubMed Web of Science ®Google Scholar
• Tarazi FI, Florijn WJ, Creese I. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment. Neuroscience. 1997;78(4):985–996.
   Web of Science ®Google Scholar
• Caligiuri MP, Lohr JB, Jeste DV. Parkinsonism in neurolepticnaive schizophrenic patients. Am J Psychiatry. 1993;150(9): 1343–1348.
   Web of Science ®Google Scholar
• Chatterjee A, Chakos M, Koreen A, et al. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry. 1995;152(12):1724–1729.
   PubMed Web of Science ®Google Scholar
• Miller DD, Andreasen NC, O’Leary DS, et al. Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography. Neuropsychopharmacology. 1997;17(4):230–240.
   PubMed Web of Science ®Google Scholar
• Corson PW, O’Leary DS, Miller DD, Andreasen NC. The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naive and medicated states. Biol Psychiatry. 2002;52(9):855–862.
   Web of Science ®Google Scholar